Lung-only metastatic pancreatic cancer: Differences in patients 'characteristics, molecular profile and survival.

Fiche publication

Date publication

janvier 2026

Journal

European journal of cancer (Oxford, England : 1990)

Auteurs

Membres identifiés du Cancéropôle Est :
Dr LAMBERT Aurélien

Tous les auteurs :
Boilève A, Mercier L, Bonnet B, Tarabay A, Blanchet-Deverly S, Hollebecque A, Smolenschi C, Valéry M, Delaye M, Pudlarz T, Fuerea A, Boige V, Durand-Labrunie J, Gelli M, Beunon P, Barbe R, Lambert A, Ducreux M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41547177

Résumé

A better prognosis is suggested for lung-only metastases patients with pancreatic ductal adenocarcinoma (PDAC), yet biological/clinical underpinnings of organotropism in PDAC remain unclear. Study objective was to compare PDAC patients depending on their metastatic site with a special focus on "lung-only" metastases patients.